RIBOCICLIB

Clinical trials for RIBOCICLIB explained in plain language.

Never miss a new study

Get alerted when new RIBOCICLIB trials appear

Sign up with your email to follow new studies for RIBOCICLIB, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 1 Completed 1

New study to track why some breast cancer patients stop taking Life-Saving pills

Knowledge-focused Not yet recruiting

This study will follow 81 people with early-stage, hormone-positive breast cancer who are at high risk of the cancer coming back. Researchers want to see how often patients stop taking their prescribed CDK4/6 inhibitor pills (abemaciclib or ribociclib) before the full treatment c…

Matched conditions: RIBOCICLIB

Sponsor: University Hospital, Grenoble • Aim: Knowledge-focused

Last updated May 26, 2026 05:44 UTC

RIBOCICLIB

Get alerted when new RIBOCICLIB trials appear

New study to track why some breast cancer patients stop taking Life-Saving pills